Mr. Speaker, I am not 100% certain where the member is getting the entirety of his information, but the fact of the matter is that the budget, in particular the cannabis excise framework, specifically says that to help those who rely on pharmaceutical cannabis products to relieve pain or treat illness, the government will exempt these products from the excise duties, so long as they are acquired through a prescription. It goes on to say, similarly, “pharmaceutical products derived from cannabis will also be exempt, provided that the cannabis product has a Drug Identification Number and can only be acquired through a prescription.”
I recognize the fact that from time to time, things change and new drugs are brought on and therefore are given identification numbers. Some take a bit longer. Perhaps everything the member is trying to encompass in his argument is not included.
Could he at least acknowledge that there is an effort to try to make sure that these particular products, when received through a prescription, will actually be exempt from the tax?